REI Flashcards
Benefits of Transdermal Estrogen replacement vs oral
- Provides 17-beta-estradiol, which is structurally identical to ovarian 17-beta-estradiol.
- Avoids the first-pass effect (which is a/w inc production of clotting factors).
- Replacement by steady infusion rather than by bolus.
- Reduces the risk of VTE vs oral route
- May be associated with a reduced risk of GB (ie, cholecystitis, cholelithiasis, and cholecystectomy)
(UTD)
Define Delayed Puberty and precocious puberty
1. No breast development age 13 No menses age 15 2. Before age 8 - < 7 caucasian - < 6 black
Most common cause Delayed Puberty
Hyper/Hypo (43%) gonadal failure
Hypo/Hypo (31%)
What does breast development suggest re: eugonadism vs hypogonadism
No breasts = hypogonadal
breasts = preduced estrogen at some point, assess current estrogen status with progestin withdrawal test
Pt with Hyper/Hypo: next step
Karyotype
- usually abn like 45x with mosaicism or 46XY (Swyer)
Hypo/Hypo pt: next step
MRI to r/o pituitary tumor
If no Tumor DDX:
- functional
- Irreversible - hypothalamic tumor, Kallmans, IHH
Eugonadism and amenorrhea DDX
Outflow obstruction
Mullerian Aplasia
AIS - no pubes, no ut/vagina s/t AMH production
Ovulatory dysfcn (PCO, Hyperprolactinemia, Thyroid dysfcn)
CASE: 17 y/o primary amenorrhea unable to smell FMx infertility Tanner 5 breast, vagina present 1. Investigations? 2. If she had no breast development would it be different?
1.
- Determine current Estrogen status - Tanner 5 breast
Progestin withdrawal bleed (Provera 10 x 10) = neg
- FSH, E2, TSH, PRL
- Bone age
2.
Yes - hypogonadism present if no breasts so no need to assess E2 status
CASE: 17 y/o primary amenorrhea unable to smell FMx infertility and anosmia Tanner 5 breast, vagina present FSH 2, Provera challenge failed 1. Dx 2. Next Step 3. Likely Cause 4. Tx
- Hypo/Hypo
- MRI
- Kallman’s
- Sex steroid replacement: Estrogen until breast development adequate then add progestin (combined OCP)
- Calcium/Vit D
- Gonadotropins for fertility
- Genetic counselling
What is the most common mutation for idiopathic Hypo/Hypo?
FGFR1
CASE: 16 y/o primary amenorrhea no breasts, short Tanner 3 pubic hair Declines pelvic 1. Ix 2. If Hyper/Hypo next steps 3. Likely Dx 4. Management
- FSH, TSH, PRL
- Karyotype
- Turners (45X)
- Remove the gonads!
- risk of cardiac /renal abn
- risk of hypothyroidism
- NO donor IVF - cardiac risks
19 y/o primary amenorrhea cervical spine immobility and joint pain no pelvic pain breasts present Tanner 5 pubic hair No vagina 1. DDX 2. most likely and what else to look at?
1.
- transverse vaginal septum or imperforate hymen (usually have pain, younger)
- complete AIS (usually Tanner 1-2)
- Mullerian aplasia
2. mullerian aplasia, kidneys
Usual time between thelarche and menarche
2-2.5 yrs
Which of the following aspects of puberty are HPO axis independent: thelarche, adrenarche, growth spurt, menarche?
Adrenarche (s/t adrenal secretion androgen)
Tanner Staging:
Breast:
- nothing
- breast bud
- mound
- secondary aoreolar mound
- adult
Pubic Hair:
- nothing
- sparse long hairs
- growth sparsely spread
- adult hair over mons
- spread to thighs